| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; loading ...; fig 1a
| Mo J, Anastasaki C, Chen Z, Shipman T, Papke J, Yin K, et al. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins. J Clin Invest. 2020;: pubmed publisher |
- immunohistochemistry - paraffin section; human; loading ...; fig 1e
| Ahfeldt T, Ordureau A, Bell C, Sarrafha L, Sun C, Piccinotti S, et al. Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Reports. 2020;14:75-90 pubmed publisher |
- immunocytochemistry; human; 1:300; loading ...; fig 4a
| Battaglia R, Beltran A, Delic S, Dumitru R, Robinson J, Kabiraj P, et al. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity. elife. 2019;8: pubmed publisher |
- immunocytochemistry; human; fig s2i
| Ercan E, Han J, Di Nardo A, Winden K, Han M, Hoyo L, et al. Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. J Exp Med. 2017;214:681-697 pubmed publisher |
- immunocytochemistry; human; 1:200; loading ...; tbl 1
| Quintanilla R, Asprer J, Sylakowski K, Lakshmipathy U. Kinetic Measurement and Real Time Visualization of Somatic Reprogramming. J Vis Exp. 2016;: pubmed publisher |
- immunocytochemistry; human; 1:100; fig 1
| Alves C, Dariolli R, Jorge F, Monteiro M, Maximino J, Martins R, et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front Cell Neurosci. 2015;9:289 pubmed publisher |
- immunocytochemistry; human; 1:100; fig 1
| Lenzi J, De Santis R, de Turris V, Morlando M, Laneve P, Calvo A, et al. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis Model Mech. 2015;8:755-66 pubmed publisher |
- western blot; human; 1:100
| Wong A, Chin S, Xia S, Garner J, Bear C, Rossant J. Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat Protoc. 2015;10:363-81 pubmed publisher |
- immunocytochemistry; human; fig 8
| Ruff D, Macarthur C, Tran H, Bergseid J, Tian J, Shannon M, et al. Applications of quantitative polymerase chain reaction protein assays during reprogramming. Stem Cells Dev. 2012;21:530-8 pubmed publisher |
- flow cytometry; human
- immunocytochemistry; human
| Hotta A, Cheung A, Farra N, Vijayaragavan K, Séguin C, Draper J, et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods. 2009;6:370-6 pubmed publisher |
| Rotundo G, Turco E, Ruotolo G, Torrente I, Candido O, Lopez G, et al. Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene. Stem Cell Res. 2023;67:103023 pubmed publisher |
| Lin H, Ye S, Xu Z, Penaloza J, Aljuhani M, Vetter T, et al. Generation and characterization of a human induced pluripotent stem cell (iPSC) line from a patient with congenital heart disease (CHD). Stem Cell Res. 2022;65:102958 pubmed publisher |
| D Anzi A, Perciballi E, Ruotolo G, Ferrari D, Notaro A, Lombardi I, et al. Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein. Stem Cell Res. 2022;63:102835 pubmed publisher |
| Cousin M, Creighton B, Breau K, Spillmann R, Torti E, Dontu S, et al. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat Genet. 2021;53:1006-1021 pubmed publisher |
| D Anzi A, Altieri F, Perciballi E, Ferrari D, Torres B, Bernardini L, et al. Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein. Stem Cell Res. 2021;53:102356 pubmed publisher |
| Beltran A, Molina S, Beltran A. Derivation of Induced Pluripotent Stem Cells from Human Fibroblasts Using a Non-integrative System in Feeder-free Conditions. Bio Protoc. 2020;10:e3788 pubmed publisher |
| Vasylovska S, Schuster J, Brboric A, Carlsson P, Dahl N, Lau J. Generation of human induced pluripotent stem cell (iPSC) lines (UUMCBi001-A, UUMCBi002-A) from two healthy donors. Stem Cell Res. 2020;50:102114 pubmed publisher |
| Fatima A, Schuster J, Akram T, Sobol M, Hoeber J, Dahl N. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9. Stem Cell Res. 2020;44:101758 pubmed publisher |
| Fatima A, Schuster J, Akram T, González C, Sobol M, Hoeber J, et al. Incontinentia pigmenti: Generation of an IKBKG deficient human iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9. Stem Cell Res. 2020;44:101739 pubmed publisher |
| Schuster J, Fatima A, Sobol M, Norradin F, Laan L, Dahl N. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations. Stem Cell Res. 2019;39:101523 pubmed publisher |
| Altieri F, D Anzi A, Martello F, Tardivo S, Spasari I, Ferrari D, et al. Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome. Stem Cell Res. 2019;38:101480 pubmed publisher |
| Schuster J, Fatima A, Schwarz F, Klar J, Laan L, Dahl N. Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations. Stem Cell Res. 2019;38:101474 pubmed publisher |
| Shrestha R, Wen Y, Ding D, Tsai R. Aberrant hiPSCs-Derived from Human Keratinocytes Differentiates into 3D Retinal Organoids that Acquire Mature Photoreceptors. Cells. 2019;8: pubmed publisher |
| Rotundo G, Bidollari E, Ferrari D, Spasari I, Bernardini L, Consoli F, et al. Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease. Stem Cell Res. 2018;29:174-178 pubmed publisher |
| Bidollari E, Rotundo G, Ferrari D, Candido O, Bernardini L, Consoli F, et al. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage. Stem Cell Res. 2018;28:145-148 pubmed publisher |
| Farzaneh M, Zare M, Hassani S, Baharvand H. Effects of various culture conditions on pluripotent stem cell derivation from chick embryos. J Cell Biochem. 2018;119:6325-6336 pubmed publisher |
| Rosati J, Altieri F, Tardivo S, Turco E, Goldoni M, Spasari I, et al. Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850). Stem Cell Res. 2018;27:74-77 pubmed publisher |
| De Angelis M, Parrotta E, Santamaria G, Cuda G. Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells. Cell Death Dis. 2018;9:6 pubmed publisher |
| Matson J, Dumitru R, Coryell P, Baxley R, Chen W, Twaroski K, et al. Rapid DNA replication origin licensing protects stem cell pluripotency. elife. 2017;6: pubmed publisher |
| Petkov S, Glage S, Niemann H. Mouse iPSC generated with porcine reprogramming factors as a model for studying the effects of non-silenced heterologous transgenes on pluripotency. J Stem Cells Regen Med. 2017;13:20-28 pubmed |
| Favaedi R, Shahhoseini M, Pakzad M, Mollamohammadi S, Baharvand H. Comparative epigenetic evaluation of human embryonic stem and induced pluripotent cells. Int J Dev Biol. 2016;60:103-10 pubmed publisher |
| Quintanilla R. Cellular characterization of human pluripotent stem cells. Methods Mol Biol. 2013;997:179-90 pubmed publisher |
| Menendez L, Kulik M, Page A, Park S, Lauderdale J, Cunningham M, et al. Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc. 2013;8:203-12 pubmed publisher |
| MacArthur C, Fontes A, Ravinder N, Kuninger D, Kaur J, Bailey M, et al. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. 2012;2012:564612 pubmed publisher |
| Henderson J, Draper J, Baillie H, Fishel S, Thomson J, Moore H, et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells. 2002;20:329-37 pubmed |
| Andrews P, Casper J, Damjanov I, Duggan Keen M, Giwercman A, Hata J, et al. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer. 1996;66:806-16 pubmed |
